N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation

References

• Liu Q, Ni W-W, Li Z, et al. Resolution and evaluation of 3-chlorophenyl-3-hydroxy-propionylhydroxamic acid as antivirulence agent with excellent eradication efficacy in Helicobacter pylori infected mice. Eur J Pharm Sci 2018;121:293–300.
   PubMed Web of Science ®Google Scholar
• Valenzuela-Valderrama M, Cerda-Opazo P, Backert S, et al. The Helicobacter pylori urease virulence factor is required for the induction of hypoxia-induced factor-1 in gastric cells. Cancers 2019;11:799.
   Web of Science ®Google Scholar
• Liu Q, Shi W-K, Ren S-Z, et al. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur J Med Chem 2018;156:126–36.
   PubMed Web of Science ®Google Scholar
• Eaton KA, Brooks CL, Morgan DR, et al. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991;59:2470–5.
   PubMed Web of Science ®Google Scholar
• Karita M, Tsuda M, Nakazawa T. Essential role of urease in vitro and in vivo Helicobacter pylori colonization study using a wild-type and isogenic urease mutant strains. J Clin Gastroenterol 1995;21:S160–S163.
   PubMed Web of Science ®Google Scholar
• Rizvi F, Khan M, Jabeen A, et al. Studies on isoniazid derivatives through a medicinal chemistry approach for the identification of new inhibitors of urease and inflammatory markers. Sci Rep 2019;9:1–14.
   PubMed Web of Science ®Google Scholar
• Shi W-K, Deng R-C, Wang P-F, et al. 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: synthesis, molecular docking and biological evaluation. Bioorg Med Chem 2016;24:4519–27.
   PubMed Web of Science ®Google Scholar
• Kanwal, Khan M, Arshia, et al. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies. Bioorg Chem 2019;83:595–610.
   PubMed Web of Science ®Google Scholar
• Rauf A, Shahzad S, Bajda M, et al. Design and synthesis of new barbituric- and thiobarbituric acid derivatives as potent urease inhibitors: structure activity relationship and molecular modeling studies. Bioorg Med Chem 2015;23:6049–58.
   PubMed Web of Science ®Google Scholar
• Yu H-Y, Guo S-H, Cheng J-Y, et al. Synthesis and crystal structures of cobalt(III), copper(II), nickel(II) and zinc(II) complexes derived from 4-methoxy-N′-(pyridin-2-ylmethylene)benzohydrazide with urease inhibitory activity. J Coord Chem 2008;61:1212–20.
   Google Scholar
• Ni W-W, Liu Q, Ren S-Z, et al. The synthesis and evaluation of phenoxyacylhydroxamic acids as potential agents for Helicobacter pylori infections. Bioorg Med Chem 2018;26:4145–52.
   PubMed Web of Science ®Google Scholar
• Xiao Z-P, Shi W-K, Wang P-F, et al. Synthesis and evaluation of N-analogues of 1,2-diarylethane as Helicobacter pylori urease inhibitors. Bioorg Med Chem 2015;23:4508–13.
   PubMed Web of Science ®Google Scholar
• Wang X-D, Wei W, Wang P-F, et al. Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent. Bioorg Med Chem 2015;23:4860–5.
   PubMedGoogle Scholar
• Xiao Z-P, Peng Z-Y, Dong J-J, et al. Synthesis, structure–activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors. Eur J Med Chem 2013;63:685–95.
   PubMed Web of Science ®Google Scholar
• Xiao Z-P, Ma T-W, Fu W-C, et al. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as H. pylori urease inhibitors. Eur J Med Chem 2010;45:5064–70.
   PubMed Web of Science ®Google Scholar
• Sivapriya K, Suguna P, Banerjee A, et al. Facile one-pot synthesis of thio and selenourea derivatives: a new class of potent urease inhibitors. Bioorg Med Chem Lett 2007;17:6387–91.
   PubMed Web of Science ®Google Scholar
• Taha M, Wadood A. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors. Bioorg Chem 2018;78:411–7.
   PubMed Web of Science ®Google Scholar
• Bano B, Kanwal, Khan KM, et al. Synthesis, in vitro urease inhibitory activity, and molecular docking studies of thiourea and urea derivatives. Bioorg Chem 2018;80:129–44.
   PubMed Web of Science ®Google Scholar
• Amtul Z, Atta-ur-Rahman BSP, Siddiqui R, et al. Chemistry and mechanism of urease inhibition. Curr Med Chem 2002;9:1323–48.
   PubMed Web of Science ®Google Scholar
• Weatherburn MW. Phenol–hypochlorite reaction for determination of ammonia. Anal Chem 1967;39:971–4.
   Web of Science ®Google Scholar
• Methods for antimicrobial susceptibility testing of anaerobic bacteria, M11. 7th ed. Wayne (PA): CLSI; 2007.
   Google Scholar
• Patil S, Sistla S, Jadhav J. Screening of inhibitors for mushroom tyrosinase using surface plasmon resonance. J Agric Food Chem 2014;62:11594–601.
   PubMed Web of Science ®Google Scholar
• SYBYL molecular modeling software, version SYBYL-X 2.1. St. Louis (MO): Tripos Inc.; 2015.
   Google Scholar
• Ha NC, Oh ST, Sung JY, et al. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 2001;8:505–9.
   PubMedGoogle Scholar
• Frostell A, Vinterbäck L, Sjöbom H. Protein-ligand interactions using SPR systems. Methods Mol Biol 2013;1008:139–65.
   PubMedGoogle Scholar
• Guo D, Hillger JM, IJzerman AP, Heitman LH. Drug-target residence time—a case for G protein-coupled receptors. Med Res Rev 2014;34:856–92.
   PubMed Web of Science ®Google Scholar
• Mazzei L, Cianci M, Musiani F, et al. Inactivation of urease by catechol: kinetics and structure. J Inorg Biochem 2017;166:182–9.
   PubMed Web of Science ®Google Scholar
• Mazzei L, Cianci M, Contaldo U, et al. Insights into urease inhibition by N-(n-butyl) phosphoric triamide through an integrated structural and kinetic approach. J Agric Food Chem 2019;67:2127–38.
   PubMed Web of Science ®Google Scholar